Besides Histone deacetylase inhibitors, elucidated by our group before,25 Aurora kinase A selective inhibitor (MLN8237) was one of the inhibitors that presented the most prominent synergistic effect with BTZ on MM cells (Figure 1C and Figure S1A,B). Here, CASC3 is linked to Miyoshi myopathy.